Search results
Psychodelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment By...
Investing.com· 3 hours agoMind Medicine (MNMD) fell as much as 13%, COMPASS Pathways plc (CMPS) declined around 10%, and Atai...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
MPR News· 4 hours agoIt represents a major setback for proponents of the drug and its sponsor Lykos Therapeutics, potentially jeopardizing FDA approval of the treatment. Following public comment and discussion, ...
Service dogs helped ease PTSD symptoms in US military veterans, researchers say
NBC New York· 15 hours agoSpecially trained service dogs helped ease PTSD symptoms in U.S. military veterans in a small study...
Service dogs helped ease PTSD symptoms in military vets, study finds
Military Times via Yahoo News· 22 hours agoSpecially trained service dogs helped ease PTSD symptoms in U.S. military veterans in a small study...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
The Cleveland Plain Dealer· 4 hours agoA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was...
Service dogs helped ease PTSD symptoms in US military veterans, researchers say
FOX23 News· 24 hours agoSpecially trained service dogs helped ease PTSD symptoms in U.S. military veterans in a small study...
Senate OKs bill adding PTSD to conditions for which first responders are eligible for compensation
Rhode Island Current via Yahoo News· 15 hours agoPROVIDENCE — The Rhode Island Senate on Tuesday voted 32-3 to pass legislation that would extend...
U.S. health experts vote against MDMA as treatment for PTSD
The Raw Story· 4 hours agoA panel of U.S. health experts convened by the Food and Drug Administration on Tuesday...
FDA Panel Says No to MDMA as Treatment for PTSD
KLAX-TV· 3 hours ago“It seems like there are so many problems with the data -- each one alone might be OK, but when you pile them on top of each other … there’s just a lot...
What's Going On With MindMed And Psychedelic Stocks? - Mind Medicine (NASDAQ:MNMD)
Benzinga· 33 minutes agoMNMD shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approval of MDMA therapy for people with post-traumatic stress disorder (PTSD< ...